The Consequences of Reconfiguring the Ambisense S Genome Segment of Rift Valley Fever Virus on Viral Replication in Mammalian and Mosquito Cells and for Genome Packaging

English version České info

Rift Valley fever virus (RVFV, family Bunyaviridae) is a mosquito-borne pathogen of both livestock and humans, found primarily in Sub-Saharan Africa and the Arabian Peninsula. The viral genome comprises two negative-sense (L and M segments) and one ambisense (S segment) RNAs that encode seven proteins. The S segment encodes the nucleocapsid (N) protein in the negative-sense and a nonstructural (NSs) protein in the positive-sense, though NSs cannot be translated directly from the S segment but rather from a specific subgenomic mRNA. Using reverse genetics we generated a virus, designated rMP12:S-Swap, in which the N protein is expressed from the NSs locus and NSs from the N locus within the genomic S RNA. In cells infected with rMP12:S-Swap NSs is expressed at higher levels with respect to N than in cells infected with the parental rMP12 virus. Despite NSs being the main interferon antagonist and determinant of virulence, growth of rMP12:S-Swap was attenuated in mammalian cells and gave a small plaque phenotype. The increased abundance of the NSs protein did not lead to faster inhibition of host cell protein synthesis or host cell transcription in infected mammalian cells. In cultured mosquito cells, however, infection with rMP12:S-Swap resulted in cell death rather than establishment of persistence as seen with rMP12. Finally, altering the composition of the S segment led to a differential packaging ratio of genomic to antigenomic RNA into rMP12:S-Swap virions. Our results highlight the plasticity of the RVFV genome and provide a useful experimental tool to investigate further the packaging mechanism of the segmented genome.

Vyšlo v časopise: The Consequences of Reconfiguring the Ambisense S Genome Segment of Rift Valley Fever Virus on Viral Replication in Mammalian and Mosquito Cells and for Genome Packaging. PLoS Pathog 10(2): e32767. doi:10.1371/journal.ppat.1003922
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003922

Souhrn

Zdroje

1. Plyusnin A, Beaty BJ, Elliott RM, Goldbach R, Kormelink R, et al. (2012) Bunyaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowits EJ, editors. Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses. London: Elsevier Academic Press. pp. 725–741

2. SmithburnKC (1949) Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br J Exp Pathol 30: 1–16.

3. MadaniTA, Al-MazrouYY, Al-JeffriMH, MishkhasAA, Al-RabeahAM, et al. (2003) Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 37: 1084–1092.

4. GerrardSR, BirdBH, AlbariñoCG, NicholST (2007) The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology 359: 459–465.

5. WonS, IkegamiT, PetersCJ, MakinoS (2006) NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol 80: 8274–8278.

6. BouloyM, WeberF (2010) Molecular biology of Rift Valley fever virus. Open Virol J 4: 8–14.

7. GiorgiC, AccardiL, NicolettiL, GroMC, TakeharaK, et al. (1991) Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology 180: 738–753.

8. Le MayN, DubaeleS, Proietti De SantisL, BillecocqA, BouloyM, et al. (2004) TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116: 541–550.

9. KalveramB, LihoradovaO, IkegamiT (2011) NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J Virol 85: 6234–6243.

10. HabjanM, PichlmairA, ElliottRM, OverbyAK, GlatterT, et al. (2009) NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 83: 4365–4375.

11. IkegamiT, NarayananK, WonS, KamitaniW, PetersCJ, et al. (2009) Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 5: e1000287.

12. KalveramB, LihoradovaO, IndranSV, LokugamageN, HeadJA, et al. (2013) Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. Virology 435: 415–424.

13. Le MayN, MansurogluZ, LegerP, JosseT, BlotG, et al. (2008) A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 4: e13.

14. BrennanB, LiP, ElliottRM (2011) Generation and characterization of a recombinant Rift Valley fever virus expressing a V5 epitope-tagged RNA-dependent RNA polymerase. J Gen Virol 92: 2906–2913.

15. BirdBH, AlbariñoCG, HartmanAL, EricksonBR, KsiazekTG, et al. (2008) Rift Valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J Virol 82: 2681–2691.

16. BirdBH, MaartensLH, CampbellS, ErasmusBJ, EricksonBR, et al. (2011) Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, non-teratogenic, and confers protection from viremia, pyrexia, and abortion following lethal challenge in adult and pregnant sheep. J Virol 85: 12901–12909.

17. IkegamiT, WonS, PetersCJ, MakinoS (2006) Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80: 2933–2940.

18. von TeichmanB, EngelbrechtA, ZuluG, DunguB, PardiniA, et al. (2011) Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves. Vaccine 29: 5771–5777.

19. BrennanB, WelchSR, McLeesA, ElliottRM (2011) Creation of a recombinant Rift Valley fever virus with a two-segmented genome. J Virol 85: 10310–10318.

20. SimonsJF, HellmanU, PetterssonRF (1990) Uukuniemi virus S RNA segment: ambisense coding strategy, packaging of complementary strands into virions, and homology to members of the genus Phlebovirus. J Virol 64: 247–255.

21. IharaT, AkashiH, BishopDH (1984) Novel coding strategy (ambisense genomic RNA) revealed by sequence analyses of Punta Toro Phlebovirus S RNA. Virology 136: 293–306.

22. NguyenM, HaenniAL (2003) Expression strategies of ambisense viruses. Virus Res 93: 141–150.

23. BishopD (1986) Ambisense RNA genomes of arenaviruses and phleboviruses. Adv Virus Res 31: 1–51.

24. IkegamiT, WonS, PetersCJ, MakinoS (2005) Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J Virol 79: 12106–12111.

25. IkegamiT, WonS, PetersCJ, MakinoS (2007) Characterization of Rift Valley fever virus transcriptional terminations. J Virol 81: 8421–8438.

26. JohnsonKN, ZeddamJL, BallLA (2000) Characterization and construction of functional cDNA clones of Pariacoto virus, the first Alphanodavirus isolated outside Australasia. J Virol 74: 5123–5132.

27. BillecocqA, GauliardN, Le MayN, ElliottRM, FlickR, et al. (2008) RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology 378: 377–384.

28. KascsakRJ, LyonsMJ (1978) Bunyamwera virus. II. The generation and nature of defective interfering particles. Virology 89: 539–546.

29. SzemielAM, FaillouxAB, ElliottRM (2012) Role of Bunyamwera Orthobunyavirus NSs Protein in Infection of Mosquito Cells. PLoS Neglect Trop Dis 6: e1823.

30. StruthersJK, SwanepoelR (1982) Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells. J Gen Virol 60: 381–384.

31. LegerP, LaraE, JaglaB, SismeiroO, MansurogluZ, et al. (2013) Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells. J Virol 87: 1631–1648.

32. JaoCY, SalicA (2008) Exploring RNA transcription and turnover in vivo by using click chemistry. Proc Natl Acad Sci U S A 105: 15779–15784.

33. KalveramB, LihoradovaO, IndranSV, HeadJA, IkegamiT (2013) Using click chemistry to measure the effect of viral infection on host-cell RNA synthesis. J Vis Exp 78: e50809.

34. MohamedM, McLeesA, ElliottRM (2009) Viruses in the Anopheles A, Anopheles B, and Tete serogroups in the Orthobunyavirus genus (family Bunyaviridae) do not encode an NSs protein. J Virol 83: 7612–7618.

35. GauliardN, BillecocqA, FlickR, BouloyM (2006) Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis. Virology 351: 170–179.

36. LowenAC, BoydA, FazakerleyJK, ElliottRM (2005) Attenuation of bunyavirus replication by rearrangement of viral coding and noncoding sequences. J Virol 79: 6940–6946.

37. LowenAC, ElliottRM (2005) Mutational analyses of the nonconserved sequences in the Bunyamwera Orthobunyavirus S segment untranslated regions. J Virol 79: 12861–12870.

38. KohlA, DunnEF, LowenAC, ElliottRM (2004) Complementarity, sequence and structural elements within the 3′ and 5′ non-coding regions of the Bunyamwera orthobunyavirus S segment determine promoter strength. J Gen Virol 85: 3269–3278.

39. KohlA, HartTJ, NoonanC, RoyallE, RobertsLO, et al. (2004) A Bunyamwera virus minireplicon system in mosquito cells. J Virol 78: 5679–5685.

40. Mazel-SanchezB, ElliottRM (2012) Attenuation of Bunyamwera orthobunyavirus replication by targeted mutagenesis of genomic untranslated regions and creation of viable viruses with minimal genome segments. J Virol 86: 13672–13678.

41. MoutaillerS, RocheB, ThibergeJM, CaroV, RougeonF, et al. (2011) Host alternation is necessary to maintain the genome stability of rift valley fever virus. PLoS Neglect Trop Dis 5: e1156.

42. CrabtreeMB, Kent CrockettRJ, BirdBH, NicholST, EricksonBR, et al. (2012) Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Neglect Trop Dis 6: e1639.

43. ElliottRM, WilkieML (1986) Persistent infection of Aedes albopictus C6/36 cells by Bunyamwera virus. Virology 150: 21–32.

44. NewtonSE, ShortNJ, DalgarnoL (1981) Bunyamwera virus replication in cultured Aedes albopictus (mosquito) cells: establishment of a persistent viral infection. J Virol 38: 1015–1024.

45. ScallanMF, ElliottRM (1992) Defective RNAs in mosquito cells persistently infected with Bunyamwera virus. J Gen Virol 73: 53–60.

46. BrackneyDE, ScottJC, SagawaF, WoodwardJE, MillerNA, et al. (2010) C6/36 Aedes albopictus cells have a dysfunctional antiviral RNA interference response. PLoS Neglect Trop Dis 4: e856.

47. MorazzaniEM, WileyMR, MurredduMG, AdelmanZN, MylesKM (2012) Production of virus-derived ping-pong-dependent piRNA-like small RNAs in the mosquito soma. PLoS Pathogens 8: e1002470.

48. SiomiMC, SatoK, PezicD, AravinAA (2011) PIWI-interacting small RNAs: the vanguard of genome defence. Nature Rev Mole Cell Biol 12: 246–258.

49. VodovarN, BronkhorstAW, van CleefKW, MiesenP, BlancH, et al. (2012) Arbovirus-derived piRNAs exhibit a ping-pong signature in mosquito cells. PloS One 7: e30861.

50. VialatP, MullerR, VuTH, PrehaudC, BouloyM (1997) Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. Virus Res 52: 43–50.

51. StruthersJK, SwanepoelR, ShepherdSP (1984) Protein synthesis in Rift Valley fever virus-infected cells. Virology 134: 118–124.

52. SwanepoelR, BlackburnNK (1977) Demonstration of nuclear immunofluorescence in Rift Valley fever infected cells. J Gen Virol 34: 557–561.

53. YadaniFZ, KohlA, PrehaudC, BillecocqA, BouloyM (1999) The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. J Virol 73: 5018–5025.

54. MurakamiS, TerasakiK, NarayananK, MakinoS (2012) Roles of the coding and noncoding regions of Rift Valley fever virus RNA genome segments in viral RNA packaging. J Virol 86: 4034–4039.

55. PiperME, SorensonDR, GerrardSR (2011) Efficient cellular release of Rift Valley fever virus requires genomic RNA. PLoS One 6: e18070.

56. HaleBG, KnebelA, BottingCH, GallowayCS, PreciousBL, et al. (2009) CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology 383: 6–11.

57. BuchholzUJ, FinkeS, ConzelmannKK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73: 251–259.

58. MasekT, VopalenskyV, SuchomelovaP, PospisekM (2005) Denaturing RNA electrophoresis in TAE agarose gels. Anal Biochem 336: 46–50.